Track topics on Twitter Track topics that are important to you
New kit enables covalent conjugation of antibodies and proteins to magnetic particles
Cambridge, UK, 21 February 2017: Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the launch of its Magnetic Conjugation Kit, the newest addition to the company’s range of particle conjugation technologies.
The new kit allows researchers to covalently conjugate antibodies and proteins to 0.5µm magnetic particles without the need for extensive optimization of the conjugation reaction, thereby saving precious antibody or protein. The Magnetic Conjugation Kit is ideal for use in immunoprecipitation experiments, as covalent attachment provides a more stable alternative to non-covalent antibody attachments using traditional Protein A or protein G resin.
The specially treated iron oxide magnetic particles offer an ideal balance between high surface area and fast separation, providing a binding capacity that is twice that of leading competitors, allowing high sensitivity to be achieved with less material and minimizing the risk of non-specific binding.
Nick Gee, CEO and CSO at Innova Biosciences, commented: “This new kit is the second product to be added to Innova’s particles range in 2017, following the launch of the Europium conjugation kit in January. We are constantly looking to develop new innovations to make scientists’ lives easier, and will be launching an additional related product later in the year.”
Innova Biosciences’ conjugation technologies include Lightning-Link® for antibody & protein labeling, InnovaCoat® GOLD nanoparticles and Latex beads for lateral flow, and Thunder-Link® for oligonucleotide conjugation.
For more information, please visit: https://www.innovabiosciences.com/magnetic-conjugation-kits/magnetic-conjugation-kit.html
Magnetic Conjugation Kit Magnetic Conjugation Kit process diagram
About Innova Biosciences Limited
Innova Biosciences are world leading experts in easy-to-use, cutting-edge bioconjugation technologies and services. The Company has the flexibility to support scientists from academia through to commercial manufacturing, developing and supplying reagent products to make science easier, both off-the shelf and to customer specification. Innova’s products are based on its antibody and protein labelling technology, nanoparticle and oligonucleotide labelling and phosphate detection enzyme assay technologies.
All of Innova Biosciences’ product ranges are of the highest quality and are designed to streamline R&D and manufacturing processes, whilst also reducing overall project costs by cutting expenses associated with e.g. material waste, in-house equipment and staff time, providing increased return on investment compared to traditional methods.
Innova Biosciences’ ever expanding portfolio, including the Lightning-Link®, InnovaCoat® and Thunder-Link® brands, is available to research laboratories, pharmaceutical, biotechnology and diagnostic companies worldwide.
Innova Biosciences is a privately held company and was founded in 2002.Media contact Katie Odgaard, Zyme Communications Email: email@example.com Phone: +44 (0)7787 502 947NEXT ARTICLE
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...